A Baltimore jury has ordered Johnson & Johnson (JNJ) and its subsidiaries to pay more than $1.5B to a woman who said decades of exposure to asbestos in the company’s talc-based products caused her peritoneal mesothelioma, Mrinmay Dey of Reuters reported. On Monday, jurors in the Circuit Court for Baltimore City found Johnson & Johnson, two of its subsidiaries, and spinoff Kenvue (KVUE) liable for failing to warn the plaintiff, Cherie Craft, that its baby powder contained asbestos.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Johnson & Johnson issues statement on Craft verdict, intends to appeal
- Johnson & Johnson (JNJ) Faces $1.56 Billion Blow in Asbestos Lawsuit
- Government deals lift overhang on pharma group, says BofA
- Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
- Johnson & Johnson announces FDA approval of TRUFILL n-BCA Liquid Embolic System